Chandok N, John S, Haider S

Language: English
References: 5
Page: 103-104
PDF size: 24.06 Kb.

Text Extraction

Dear Editor,

With the improved efficacy of highly active antiretroviral therapy (HAART) for management of human immunodeficiency virus (HIV), hepatitis C virus (HCV) has emerged as a significant cause of morbidity and mortality in the HIV population. The multinational CEASAR study estimated that the overall global prevalence of HCV/HIV coinfection in the HIV population is approximately16%, establishing HCV coinfection as a major challenge in HIV care.

REFERENCES

1. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C coinfection within the CAESAR study. HIV Med 2004; 5(3): 174-9.

2. Sherman KE, O’Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31(10): 2679-82.

3. Andersson K, Chung RT. Hepatitis C Virus in the HIV-infected patient. Clin Liver Dis 2006; 10(2): 303-20, viii.

4. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-Infected Person. Ann Intern Med 2003; 138(3): 197-207.

5. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33(4): 562-9.